CASE REPORT
The utility of molecular diagnostics in tumour surveillance in Beckwith-Wiedemann syndrome – clinical genetics point of view in light of a case report
Submission date: 2018-10-27
Final revision date: 2018-12-17
Acceptance date: 2018-12-18
Publication date: 2019-01-07
Pediatr Pol 2018;93(6):479-483
KEYWORDS
TOPICS
ABSTRACT
Beckwith-Wiedemann syndrome (BWS) is the most frequent congenital overgrowth syndrome. Its clinical features are variable, including macrosomia, hemihyperplasia, and macroglossia. The most important feature appears to be the increased risk of embryonal tumours, depending on the molecular aetiology of BWS. The underlying molecular abnormalities might be genetic or epigenetic, and they involve the segment of the genome – chromosome 11p15.
The aim of the study is to present the case report of a patient with BWS, who was at the highest molecular risk of developing embryonal tumour associated with this syndrome. The authors emphasise the importance of therapy individualisation in BWS due to variable cancer predispositions associated with molecular aetiology.
The aim of the study is to present the case report of a patient with BWS, who was at the highest molecular risk of developing embryonal tumour associated with this syndrome. The authors emphasise the importance of therapy individualisation in BWS due to variable cancer predispositions associated with molecular aetiology.
REFERENCES (24)
1.
Mussa A, Molinatto C, Baldassarre G, et al. Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol. J Pediatr 2016; 176: 142-149.e1.
2.
Pappas JG. The Clinical Course of an Overgrowth Syndrome, From Diagnosis in Infancy Through Adulthood: The Case of Beckwith-Wiedemann Syndrome. Curr Probl Pediatr Adolesc Health Care 2015; 45: 112-117.
3.
Giżewska M, Wilk M, Patalan M, et al. The significance of molecular studies in the long-term follow-up of children with Beckwith-Wiedemann syndrome. Turk J Pediatr 2014; 56: 177-182.
4.
Ferianec V, Bartova M. Beckwith-Wiedemann syndrome with overlapping Perlman syndrome manifestation. J Matern Neonatal Med 2014; 27: 1607-1609.
5.
Cohen MM. Beckwith-Wiedemann Syndrome: Historical, Clinicopathological, and Etiopathogenetic Perspectives. Pediatr Dev Pathol 2005; 8: 287-304.
6.
Brzezinski J, Shuman C, Choufani S, et al. Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines. Eur J Hum Genet 2017; 25: 1031-1039.
7.
Brioude F, Lacoste A, Netchine I, et al. Beckwith-Wiedemann Syndrome: Growth Pattern and Tumor Risk according to Molecular Mechanism, and Guidelines for Tumor Surveillance. Horm Res Paediatr 2013; 80: 457-465.
8.
Style CC, Cruz SM, Lau PE, et al. Surgical Outcomes of Patients with Beckwith-Wiedemann Syndrome. J Pediatr Surg 2018; 53: 1042-1045.
9.
Shuman C, Beckwith JB, Weksberg R. Beckwith-Wiedemann Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds.). GeneRev [Internet], University of Washington, Seattle 1993-2018.
10.
Sparago A, Russo S, Cerrato F, et al. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms’ tumour. Hum Mol Genet 2007; 16: 254-264.
11.
Maas SM, Vansenne F, Kadouch DJ, et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A 2016; 170: 2248-2260.
12.
Mussa A, Peruzzi L, Chiesa N, et al. Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. Pediatr Nephrol 2012; 27: 397-406.
13.
Kalish J, Deardorff M. Tumor screening in Beckwith-Wiedemann syndrome – To screen or not to screen? Am J Med Genet A 2016; 170: 2261-2264.
14.
Bhatnagar S. Management of Wilms’ tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg 2009; 14: 6-14.
15.
Mussa A, Russo S, De Crescenzo A, et al. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. Eur J Hum Genet 2016; 24: 183-190.
16.
Brioude F, Kalish J, Mussa A, et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol 2018; 14: 229-249.
17.
Strenger V, Kerbl R, Dornbusch H, et al. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer 2007; 48: 504-509.
18.
Dome JS, Perlman EJ, Graf N. Risk Stratification for Wilms Tumor: Current Approach and Future Directions. Am Soc Clin Oncol Educ B 2014; 34: 215-223.
19.
Kinoshita Y, Suminoe A, Inada H, et al. The prognostic significance of blastemal predominant histology in initially resected Wilms’ tumors: A report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan. J Pediatr Surg 2012; 47: 2205-2209.
20.
McNeil DE, Langer JC, Choyke P, et al. Feasibility of partial nephrectomy for Wilms’ tumor in children with Beckwith-Wiedemann syndrome who have been screened with abdominal ultrasonography. J Pediatr Surg 2002; 37: 57-60.
22.
Kliegman R, Lye PS, Bordini BJ, et al. Nelson pediatric symptom-based diagnosis. Elsevier, Philadelphia 2018; 816.
23.
Munns CF, Batch JA. Hyperinsulinism and Beckwith-Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed 2001; 84: F67-69.
24.
Niikawa N, Ishikiriyama S, Takahashi S, et al. The Wiedemann-Beckwith syndrome: pedigree studies on five families with evidence for autosomal dominant inheritance with variable expressivity. Am J Med Genet 1986; 24: 41-55.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
